Detalhe da pesquisa
1.
HER2 mutation as an emerging target in advanced breast cancer.
Cancer Sci
; 2024 May 07.
Artigo
Inglês
| MEDLINE | ID: mdl-38715247
2.
Role of Hippo pathway dysregulation from gastrointestinal premalignant lesions to cancer.
J Transl Med
; 22(1): 213, 2024 Feb 29.
Artigo
Inglês
| MEDLINE | ID: mdl-38424512
3.
Bcl-2 dependent modulation of Hippo pathway in cancer cells.
Cell Commun Signal
; 22(1): 277, 2024 May 16.
Artigo
Inglês
| MEDLINE | ID: mdl-38755629
4.
The Molecular Tumor Board of the Regina Elena National Cancer Institute: from accrual to treatment in real-world.
J Transl Med
; 21(1): 725, 2023 10 16.
Artigo
Inglês
| MEDLINE | ID: mdl-37845764
5.
Biomarkers of Response and Resistance to CDK4/6 Inhibitors in Breast Cancer: Hints from Liquid Biopsy and microRNA Exploration.
Int J Mol Sci
; 23(23)2022 Nov 22.
Artigo
Inglês
| MEDLINE | ID: mdl-36498861
6.
Correction to: Role of Hippo pathway dysregulation from gastrointestinal premalignant lesions to cancer.
J Transl Med
; 22(1): 420, 2024 May 03.
Artigo
Inglês
| MEDLINE | ID: mdl-38702720
7.
CHK1-targeted therapy to deplete DNA replication-stressed, p53-deficient, hyperdiploid colorectal cancer stem cells.
Gut
; 67(5): 903-917, 2018 05.
Artigo
Inglês
| MEDLINE | ID: mdl-28389531
8.
GLUT 1 receptor expression and circulating levels of fasting glucose in high grade serous ovarian cancer.
J Cell Physiol
; 233(2): 1396-1401, 2018 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-28542798
9.
Neoadjuvant chemotherapy in triple-negative breast cancer: A multicentric retrospective observational study in real-life setting.
J Cell Physiol
; 233(3): 2313-2323, 2018 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-28710865
10.
Coexisting YAP expression and TP53 missense mutations delineates a molecular scenario unexpectedly associated with better survival outcomes in advanced gastric cancer.
J Transl Med
; 16(1): 247, 2018 09 04.
Artigo
Inglês
| MEDLINE | ID: mdl-30180862
11.
Observational study of coagulation activation in early breast cancer: development of a prognostic model based on data from the real world setting.
J Transl Med
; 16(1): 129, 2018 05 16.
Artigo
Inglês
| MEDLINE | ID: mdl-29769125
12.
Expression of the Hippo transducer TAZ in association with WNT pathway mutations impacts survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy.
J Transl Med
; 16(1): 22, 2018 02 05.
Artigo
Inglês
| MEDLINE | ID: mdl-29402328
13.
Association between AXL, Hippo Transducers, and Survival Outcomes in Male Breast Cancer.
J Cell Physiol
; 232(8): 2246-2252, 2017 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-27987320
14.
A Real-World Multicentre Retrospective Study of Paclitaxel-Bevacizumab and Maintenance Therapy as First-Line for HER2-Negative Metastatic Breast Cancer.
J Cell Physiol
; 232(6): 1571-1578, 2017 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-27861874
15.
DNA damage repair and survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy.
Int J Cancer
; 140(11): 2587-2595, 2017 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28233295
16.
Body mass index modifies the relationship between γ-H2AX, a DNA damage biomarker, and pathological complete response in triple-negative breast cancer.
BMC Cancer
; 17(1): 101, 2017 Feb 06.
Artigo
Inglês
| MEDLINE | ID: mdl-28166748
17.
ESAS and FACT-B in eribulin-treated metastatic breast cancer patients: a multicenter, prospective and observational study.
Future Oncol
; 13(17): 1517-1525, 2017 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-28429617
18.
Neoadjuvant Sequential Docetaxel Followed by High-Dose Epirubicin in Combination With Cyclophosphamide Administered Concurrently With Trastuzumab. The DECT Trial.
J Cell Physiol
; 231(11): 2541-7, 2016 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-27187274
19.
Body Mass Index and Treatment Outcomes in Metastatic Breast Cancer Patients Treated With Eribulin.
J Cell Physiol
; 231(5): 986-91, 2016 May.
Artigo
Inglês
| MEDLINE | ID: mdl-26449308
20.
Anthropometric, metabolic and molecular determinants of human epidermal growth factor receptor 2 expression in luminal B breast cancer.
J Cell Physiol
; 230(8): 1708-12, 2015 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-25510909